Editorial: Ubiquitin-Modifying Enzymes as Drug Targets and Biomarkers in Cancer

• Jessica L. Bell,
• Alena Malyukova,
• Jean B. Bertoldo,
• Matthew K. Summers,
• Yi Sun

Affiliations

Jessica L. Bell

Children’s Cancer Institute, School of Women’s and Children’s Health, Lowy Cancer Centre, University of New South Wales (UNSW), Sydney, NSW, Australia

Alena Malyukova

Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden

Jean B. Bertoldo

Institute of Molecular Medicine, Faculty of Medicine, Martin-Luther University of Halle-Wittenberg, Halle, Germany

Matthew K. Summers

Department of Radiation Oncology, Arthur G James Comprehensive Cancer Center and Richard L. Solove Research Institute, The Ohio State University, Columbus, OH, United States

Yi Sun

Cancer Institute, The Second Affiliated Hospital, and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China